Farther Finance Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.3K	Buy	1,743 +199	+13%	+$4.74K	﹤0.01%	3091
2025 Q4	$36K	Sell	1,544 -97	-6%	-$2.16K	﹤0.01%	3022
2025 Q3	$32.3K	Buy	1,641 +119	+8%	+$2.45K	﹤0.01%	2721
2025 Q2	$33K	Sell	1,522 -142	-9%	-$3.35K	﹤0.01%	2357
2025 Q1	$39.8K	Sell	1,664 -1,026	-38%	-$23.1K	﹤0.01%	2009
2024 Q4	$56.1K	Buy	2,690 +1,495	+125%	+$32.1K	﹤0.01%	1600
2024 Q3	$23.8K	Buy	1,195 +713	+148%	+$13.2K	﹤0.01%	2004
2024 Q2	$7.6K	Buy	482 +70	+17%	+$1.09K	﹤0.01%	2188
2024 Q1	$6.49K	Buy	412 +9	+2%	+$136	﹤0.01%	1947
2023 Q4	$6.77K	Sell	403 -165	-29%	-$2.25K	﹤0.01%	1816
2023 Q3	$6.64K	Hold	568	–	–	﹤0.01%	1422
2023 Q2	$7.63K	Hold	568	–	–	﹤0.01%	1281
2023 Q1	$9.42K	Hold	568	–	–	﹤0.01%	1137
2022 Q4	$10.6K	Buy	+568	New	+$8.74K	﹤0.01%	929